LAXOBERON Side Effects

6371888-2 | Delirium
on Sep 18, 2009 Female patient from JAPAN , 73 years of age, was diagnosed with insomnia and was treated with Laxoberon (View Usage). Patient experienced the following unwanted or unexpected effects: delirium. Laxoberon dosage: Unk. During the same period patient was treated with MAGMITT (Unk) (View Magmitt Review and Magmitt Label ), NORVASC (Unk) (View Norvasc Review and Norvasc Label ), BLOPRESS (Unk) (View Blopress Review and Blopress Label ), MYSLEE (View Myslee Review and Myslee Label ), BENET (Unk) (View Benet Review and Benet Label ), VEMAS S (Unk) (View Vemas S Review and Vemas S Label ).

6192060-5 | Respiratory Depression
Patient was taking Laxoberon (View Usage). Patient had the following side effects: respiratory depression on May 06, 2009 from SWITZERLAND Additional patient health information: Male patient , 45 years of age, . Laxoberon dosage: . During the same period patient was treated with MYCOSTATIN (View Mycostatin Review and Mycostatin Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), FOLVITE (View Folvite Review and Folvite Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), MEPHAMESON (View Mephameson Review and Mephameson Label ), ELIXIR FRANGULAE COMPOSITUM (View Elixir Frangulae Compositum Review and Elixir Frangulae Compositum Label ), XANAX (View Xanax Review and Xanax Label ).

6160865-2 | Respiratory Depression
Adverse event was reported on Apr 08, 2009 by a Male patient taking Laxoberon (View Usage) (Dosage: ) . Location: SWITZERLAND , 45 years of age, After Laxoberon was administered, patient had the following side effects: respiratory depression. During the same period patient was treated with MYCOSTATIN (View Mycostatin Review and Mycostatin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), FOLVITE (View Folvite Review and Folvite Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), MEPHAMESON (View Mephameson Review and Mephameson Label ), ELIXIR FRANGULAE COMPOSITUM (View Elixir Frangulae Compositum Review and Elixir Frangulae Compositum Label ), XANAX (View Xanax Review and Xanax Label ).

6055726-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholestasis, Hepatic Function Abnormal
on Jan 21, 2009 Male patient from JAPAN , weighting 112.4 lb, was diagnosed with constipation (What is constipation?), cerebral thrombosis and was treated with Laxoberon (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, hepatic function abnormal. Laxoberon dosage: . During the same period patient was treated with MAGMITT (View Magmitt Review and Magmitt Label ), RADICUT (Unk) (View Radicut Review and Radicut Label ), ARGATROBAN (Unk) (View Argatroban Review and Argatroban Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.


5931854-5 | Hypoglycaemia
on Oct 14, 2008 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with constipation (What is constipation?), diabetes mellitus, hyperlipidaemia, hypertension and was treated with Laxoberon (View Usage). Patient had the following side effects: hypoglycaemia. Laxoberon dosage: Unk. During the same period patient was treated with SENNOSIDE A+B (0.5 G) (View Sennoside A+b Review and Sennoside A+b Label ), NITRODERM (Unk) (View Nitroderm Review and Nitroderm Label ), LANSOPRAZOLE (15 Mg) (View Lansoprazole Review and Lansoprazole Label ), HUMALOG (Unk) (View Humalog Review and Humalog Label ), BASEN OD (View Basen Od Review and Basen Od Label ), EPADEL S (View Epadel S Review and Epadel S Label ), SIMVASTATIN (5 Mg) (View Simvastatin Review and Simvastatin Label ), ARTIST (2.5 Mg) (View Artist Review and Artist Label ). Patient was hospitalized.

5872289-3 | Hypoglycaemia
Patient was taking Laxoberon (View Usage). After Laxoberon was administered, patient had the following side effects: hypoglycaemia on Aug 26, 2008 from JAPAN Additional patient health information: Male patient , weighting 154.3 lb, was diagnosed with diabetes mellitus, hyperlipidaemia, hypertension and. Laxoberon dosage: Unk. During the same period patient was treated with SENNOSIDE A+B (0.5 G) (View Sennoside A+b Review and Sennoside A+b Label ), NITRODERM (Unk) (View Nitroderm Review and Nitroderm Label ), LANSOPRAZOLE (15 Mg) (View Lansoprazole Review and Lansoprazole Label ), HUMALOG (Unk) (View Humalog Review and Humalog Label ), BASEN OD (View Basen Od Review and Basen Od Label ), EPADEL S (View Epadel S Review and Epadel S Label ), SIMVASTATIN (5 Mg) (View Simvastatin Review and Simvastatin Label ), ARTIST (2.5 Mg) (View Artist Review and Artist Label ). Patient was hospitalized.

5729430-2 | Hepatic Failure
Adverse event was reported on Apr 24, 2008 by a Female patient taking Laxoberon (View Usage) (Dosage: Unk) was diagnosed with hypertension, cardiac failure, gastritis, lacunar infarction, atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: hepatic failure. During the same period patient was treated with HERBESSER (View Herbesser Review and Herbesser Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SELBEX (View Selbex Review and Selbex Label ), PLAVIX (View Plavix Review and Plavix Label ), VASOLAN (View Vasolan Review and Vasolan Label ). Patient was hospitalized and became disabled.

5704657-4 | Liver Disorder, Platelet Count Decreased, Psychiatric Symptom, Renal Disorder
on Apr 02, 2008 Female patient from JAPAN , 86 years of age, weighting 101.4 lb, was diagnosed with lacunar infarction and was treated with Laxoberon (View Usage). Patient had the following side effects: liver disorder, platelet count decreased, psychiatric symptom, renal disorder. Laxoberon dosage: Unk. During the same period patient was treated with DILTIAZEM HCL (Unk) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), HALFDIGOXIN (Unk) (View Halfdigoxin Review and Halfdigoxin Label ), SELBEX (Unk) (View Selbex Review and Selbex Label ), VASOLAN (Unk) (View Vasolan Review and Vasolan Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized and became disabled.

5694941-5 | Liver Disorder, Platelet Count Decreased, Psychiatric Symptom, Renal Disorder
on Apr 02, 2008 Female patient from JAPAN , 86 years of age, weighting 101.4 lb, was diagnosed with lacunar infarction and was treated with Laxoberon (View Usage). After Laxoberon was administered, patient had the following side effects: liver disorder, platelet count decreased, psychiatric symptom, renal disorder. Laxoberon dosage: Unk. During the same period patient was treated with DILTIAZEM HCL (Unk) (View Diltiazem Hcl Review and Diltiazem Hcl Label ), HALFDIGOXIN (Unk) (View Halfdigoxin Review and Halfdigoxin Label ), SELBEX (Unk) (View Selbex Review and Selbex Label ), VASOLAN (Unk) (View Vasolan Review and Vasolan Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized and became disabled.

5248035-3 | Aggression, Delirium
Patient was taking Laxoberon (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, delirium on Feb 20, 2007 from JAPAN Additional patient health information: Female patient , 87 years of age, weighting 99.21 lb, was diagnosed with constipation (What is constipation?), multiple myeloma (What is multiple myeloma?), reflux oesophagitis, cardiac failure, hypertension, insomnia, hyperuricaemia and. Laxoberon dosage: 2.5 Mg. During the same period patient was treated with OXYCONTIN (5 Mg) (View Oxycontin Review and Oxycontin Label ), OMEPRAL (20 Mg) (View Omepral Review and Omepral Label ), FRANDOL S (40 Mg) (View Frandol S Review and Frandol S Label ), AMLODIPINE (2.5 Mg) (View Amlodipine Review and Amlodipine Label ), MYSLEE (5 Mg) (View Myslee Review and Myslee Label ), ALLOPURINOL (50 Mg) (View Allopurinol Review and Allopurinol Label ).

5239702-6 | Delirium
Adverse event was reported on Feb 06, 2007 by a Female patient taking Laxoberon (View Usage) (Dosage: 2.5 Mg) was diagnosed with constipation (What is constipation?), multiple myeloma (What is multiple myeloma?), reflux oesophagitis, cardiac failure, hypertension, hyperuricaemia, insomnia and. Location: JAPAN , 87 years of age, weighting 99.21 lb, Patient had the following side effects: delirium. During the same period patient was treated with OXYCONTIN (5 Mg) (View Oxycontin Review and Oxycontin Label ), OMEPRAL (20 Mg) (View Omepral Review and Omepral Label ), FRANDOL S (40 Mg) (View Frandol S Review and Frandol S Label ), AMLODIN (2.5 Mg) (View Amlodin Review and Amlodin Label ), ZYLORIC (50 Mg) (View Zyloric Review and Zyloric Label ), MYSLEE (5 Mg) (View Myslee Review and Myslee Label ).